275 related articles for article (PubMed ID: 7774641)
1. Restoration of endogenous antigen processing in Burkitt's lymphoma cells by Epstein-Barr virus latent membrane protein-1: coordinate up-regulation of peptide transporters and HLA-class I antigen expression.
Rowe M; Khanna R; Jacob CA; Argaet V; Kelly A; Powis S; Belich M; Croom-Carter D; Lee S; Burrows SR
Eur J Immunol; 1995 May; 25(5):1374-84. PubMed ID: 7774641
[TBL] [Abstract][Full Text] [Related]
2. Targeting tumour cells with defects in the MHC Class I antigen processing pathway with CD8+ T cells specific for hydrophobic TAP- and Tapasin-independent peptides: the requirement for directed access into the ER.
Aladin F; Lautscham G; Humphries E; Coulson J; Blake N
Cancer Immunol Immunother; 2007 Aug; 56(8):1143-52. PubMed ID: 17143611
[TBL] [Abstract][Full Text] [Related]
3. Sustained complete responses in patients with lymphoma receiving autologous cytotoxic T lymphocytes targeting Epstein-Barr virus latent membrane proteins.
Bollard CM; Gottschalk S; Torrano V; Diouf O; Ku S; Hazrat Y; Carrum G; Ramos C; Fayad L; Shpall EJ; Pro B; Liu H; Wu MF; Lee D; Sheehan AM; Zu Y; Gee AP; Brenner MK; Heslop HE; Rooney CM
J Clin Oncol; 2014 Mar; 32(8):798-808. PubMed ID: 24344220
[TBL] [Abstract][Full Text] [Related]
4. CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors.
Ma Y; Walsh MJ; Bernhardt K; Ashbaugh CW; Trudeau SJ; Ashbaugh IY; Jiang S; Jiang C; Zhao B; Root DE; Doench JG; Gewurz BE
Cell Host Microbe; 2017 May; 21(5):580-591.e7. PubMed ID: 28494239
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive epitope mapping of the Epstein-Barr virus latent membrane protein-2 in normal, non tumor-bearing individuals.
Provenzano M; Selleri S; Jin P; Wang E; Werden R; Slezak S; Adams SD; Panelli MC; Leitman SF; Stroncek DF; Marincola FM
Cancer Immunol Immunother; 2007 Jul; 56(7):1047-63. PubMed ID: 17124584
[TBL] [Abstract][Full Text] [Related]
6. Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells.
Cahir-McFarland ED; Carter K; Rosenwald A; Giltnane JM; Henrickson SE; Staudt LM; Kieff E
J Virol; 2004 Apr; 78(8):4108-19. PubMed ID: 15047827
[TBL] [Abstract][Full Text] [Related]
7. LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells.
Zhang J; Sommermann T; Li X; Gieselmann L; de la Rosa K; Stecklum M; Klein F; Kocks C; Rajewsky K
Front Immunol; 2023; 14():1331730. PubMed ID: 38169736
[TBL] [Abstract][Full Text] [Related]
8. The production of a new MAGE-3 peptide presented to cytolytic T lymphocytes by HLA-B40 requires the immunoproteasome.
Schultz ES; Chapiro J; Lurquin C; Claverol S; Burlet-Schiltz O; Warnier G; Russo V; Morel S; Lévy F; Boon T; Van den Eynde BJ; van der Bruggen P
J Exp Med; 2002 Feb; 195(4):391-9. PubMed ID: 11854353
[TBL] [Abstract][Full Text] [Related]
9. Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination.
Ranieri E; Herr W; Gambotto A; Olson W; Rowe D; Robbins PD; Kierstead LS; Watkins SC; Gesualdo L; Storkus WJ
J Virol; 1999 Dec; 73(12):10416-25. PubMed ID: 10559360
[TBL] [Abstract][Full Text] [Related]
10. Epstein-barr virus nuclear antigen 1 sequences in endemic and sporadic Burkitt's lymphoma reflect virus strains prevalent in different geographic areas.
Habeshaw G; Yao QY; Bell AI; Morton D; Rickinson AB
J Virol; 1999 Feb; 73(2):965-75. PubMed ID: 9882297
[TBL] [Abstract][Full Text] [Related]
11. Crossreactive recognition of viral, self, and bacterial peptide ligands by human class I-restricted cytotoxic T lymphocyte clonotypes: implications for molecular mimicry in autoimmune disease.
Misko IS; Cross SM; Khanna R; Elliott SL; Schmidt C; Pye SJ; Silins SL
Proc Natl Acad Sci U S A; 1999 Mar; 96(5):2279-84. PubMed ID: 10051632
[TBL] [Abstract][Full Text] [Related]
12. Targeting a polyepitope protein incorporating multiple class II-restricted viral epitopes to the secretory/endocytic pathway facilitates immune recognition by CD4+ cytotoxic T lymphocytes: a novel approach to vaccine design.
Thomson SA; Burrows SR; Misko IS; Moss DJ; Coupar BE; Khanna R
J Virol; 1998 Mar; 72(3):2246-52. PubMed ID: 9499082
[TBL] [Abstract][Full Text] [Related]
13. Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation.
Yang L; Hakoda M; Iwabuchi K; Takeda T; Koike T; Kamatani N; Takada K
J Virol; 2004 Sep; 78(18):9918-23. PubMed ID: 15331725
[TBL] [Abstract][Full Text] [Related]
14. Reactive oxygen signaling and MAPK activation distinguish Epstein-Barr Virus (EBV)-positive versus EBV-negative Burkitt's lymphoma.
Cerimele F; Battle T; Lynch R; Frank DA; Murad E; Cohen C; Macaron N; Sixbey J; Smith K; Watnick RS; Eliopoulos A; Shehata B; Arbiser JL
Proc Natl Acad Sci U S A; 2005 Jan; 102(1):175-9. PubMed ID: 15611471
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma renders tumors that express low levels of Her-2/neu sensitive to cytotoxic T cells.
Kaplan BL; Norell H; Callender GG; Ohlum T; Kiessling R; Nishimura MI
Cancer Immunol Immunother; 2006 Jun; 55(6):653-62. PubMed ID: 16151808
[TBL] [Abstract][Full Text] [Related]
16. Cloning and analysis of the Epstein-Barr virus glycoprotein 350 genes.
Chang SH; Kim SH; Lee WK; Kim HJ; Choi SH; Park JH; Jang HS; Chung GH; Kwon TH; Kim DH; Yang MS; Jang YS
Mol Cells; 1998 Oct; 8(5):585-93. PubMed ID: 9856346
[TBL] [Abstract][Full Text] [Related]
17. Search for the critical characteristics of phenotypically different B cell lines, Burkitt lymphoma cells and lymphoblastoid cell lines, which determine differences in their functional interaction with allogeneic lymphocytes.
Avila-Cariño J; Torsteinsdottir S; Ehlin-Henriksson B; Masucci MG; Klein E
Cancer Immunol Immunother; 1991; 34(2):128-32. PubMed ID: 1722139
[TBL] [Abstract][Full Text] [Related]
18. Role of metalloproteases in vaccinia virus epitope processing for transporter associated with antigen processing (TAP)-independent human leukocyte antigen (HLA)-B7 class I antigen presentation.
Lorente E; García R; Mir C; Barriga A; Lemonnier FA; Ramos M; López D
J Biol Chem; 2012 Mar; 287(13):9990-10000. PubMed ID: 22298786
[TBL] [Abstract][Full Text] [Related]
19. Preferential localization of the Epstein-Barr virus (EBV) oncoprotein LMP-1 to nuclei in human T cells: implications for its role in the development of EBV genome-positive T-cell lymphomas.
Xu J; Ahmad A; Menezes J
J Virol; 2002 Apr; 76(8):4080-6. PubMed ID: 11907247
[TBL] [Abstract][Full Text] [Related]
20. Viral DNA contamination is responsible for Epstein-Barr virus detection in cytotoxic T lymphocytes stimulated in vitro with Epstein-Barr virus B-lymphoblastoid cell line.
Berthomé M; Gallot G; Vivien R; Clémenceau B; Nguyen JM; Coste-Burel M; Vié H
Cancer Immunol Immunother; 2010 Dec; 59(12):1867-75. PubMed ID: 20809356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
